Document is current
Any future updates will be listed below
-
Authors
Rabenstein, Andrea http://orcid.org/0000-0002-4844-9021
Catarino, Claudia B.
Rampeltshammer, Verena
Schindler, David
Gallenmüller, Constanze
Priglinger, Claudia
Pogarell, Oliver
Rüther, Tobias
Klopstock, Thomas
-
Funding
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (01GM1113A)
- License Information
-
More Information
Article History
Received: 12 June 2020
Accepted: 2 February 2021
First Online: 11 March 2021
Ethics approval and consent to participate
: This study was approved by the local Ethics committee of the Ludwig-Maximilians-University (LMU) of Munich (project number 278–13) and conformed to the principles of Good Clinical Practice.
: All participants and legal guardians (for participants under the age of 18 years) gave written informed consent or assent.
: TK has been principal investigator or investigator in industry-sponsored trials funded by Santhera Pharmaceuticals and GenSight Biologics, served on scientific advisory board and received speaker honoraria and travel costs from Santhera Pharmaceuticals and GenSight Biologics. CBC received travel costs from Santhera Pharmaceuticals and GenSight Biologics. AR, CG, CP, DS, OP, TR and VR report no disclosures.
